Patent 11951038 was granted and assigned to Mati Therapeutics on April, 2024 by the United States Patent and Trademark Office.
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.